Aethlon Medical, Inc.
AEMD
$1.59
$0.042.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -31.61% | -40.33% | -32.65% | -8.60% | -23.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.61% | -40.33% | -32.65% | -8.60% | -23.10% |
| Operating Income | 31.61% | 40.33% | 32.65% | 8.60% | 23.10% |
| Income Before Tax | 31.48% | -157.89% | 49.37% | 7.50% | 21.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.48% | -157.89% | 49.37% | 7.50% | 21.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.48% | -157.89% | 49.37% | 7.50% | 21.66% |
| EBIT | 31.61% | 40.33% | 32.65% | 8.60% | 23.10% |
| EBITDA | 32.55% | 41.33% | 33.50% | 8.68% | 23.60% |
| EPS Basic | 69.24% | 53.55% | 90.88% | 83.52% | 74.46% |
| Normalized Basic EPS | 69.24% | 65.84% | 87.80% | 83.52% | 74.46% |
| EPS Diluted | 69.24% | 53.55% | 90.88% | 83.52% | 74.46% |
| Normalized Diluted EPS | 69.24% | 65.84% | 87.80% | 83.52% | 74.46% |
| Average Basic Shares Outstanding | 122.74% | 455.19% | 454.77% | 461.10% | 206.75% |
| Average Diluted Shares Outstanding | 122.74% | 455.19% | 454.77% | 461.10% | 206.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |